Belite Bio, Inc
NASDAQ:BLTE
62 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||||||||
Net Income
| -0.009 | -0.008 | -0.007 | -0.011 | -0.007 | -0.007 | -0.007 | -0.002 | -0.002 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | -0.023 | 0 | 0 | 0 | 0 | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | -5.351 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0.004 | 0 | 0 | 0 | 0.001 | 0.001 | 0 | 0 | -0 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | -0.48 | 0 | 0 | 0 | 0 | 0.16 | -0 | -0 | 0 | 0 | -0 | -0 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
Other Non Cash Items
| 0.009 | 0.008 | 0.003 | 0.011 | 0.007 | 0.007 | 0.005 | 0.002 | 0.002 | 0.001 | 0.001 | 0.002 | 0 | 0 | 0 | 0 | -0 | -0 |
Operating Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | -5.853 | 0.001 | 0 | 0 | -0.002 | -1.869 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 |
Investing Activities: | ||||||||||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0.056 | 0 | 0 | 0 | -0.019 | -0.019 | -0 | -0 | -0 | -0 | -0.005 | -0.005 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | -0.431 | 0 | 0 | 0 | 0 | 0.019 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0.005 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | -0.376 | 0 | 0 | 0 | 0 | -0.019 | -0 | -0 | -0 | -0 | -0.005 | -0.005 |
Financing Activities: | ||||||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.125 | 0.125 | 0.125 | 0.125 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 37.167 | 0 | 0 | 0 | -0 | -0.204 | -0.204 | -0.204 | 0.011 | 0.011 | 0.003 | 0.003 |
Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 37.167 | 0 | 0 | 0 | -0 | -0.204 | -0.204 | -0.204 | 0.011 | 0.011 | 0.003 | 0.003 |
Other Information: | ||||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | -0.366 | 0 | 0 | 0 | -0 | 0.022 | -0 | -0 | -0 | -0 | 0 | 0 |
Net Change In Cash
| 0 | 0 | 0 | -2.9 | 19.6 | 0 | 37.753 | 0.001 | 0 | 0 | -2.069 | -2.069 | -2.069 | -2.069 | 5.9 | 6.398 | -0.497 | 5.9 |
Cash At End Of Period
| 0 | 0 | 0 | 54.5 | 57.4 | 0 | 42.089 | 0.001 | 0 | 0 | 4.336 | 4.336 | 4.336 | 4.336 | 6.405 | 6.405 | 0.007 | 6.405 |